Original language | English |
---|---|
Pages (from-to) | 55-57 |
Journal | Tumor Targeting |
Volume | 3 |
Publication status | Published - 1998 |
Clinical study to investigate the potential of an engineered human monoclonal antibody, hCTM01, for targeted chemotherapy of ovarian cancer
T.J. Broadhead, Q. Davies, A.C. van Hof, C.F.M. Molthoff, A.C. Perkins, J.C. Roos, W.M. Prinssen, RHM Verheijen, W. Hollander, M. Sopwith, M. Frier, P. Kenemans, E.M. Symonds
Research output: Contribution to journal › Article › Academic › peer-review